Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
This study has been completed.
Study NCT00640926 Information provided by Rib-X Pharmaceuticals, Inc.
First Received on March 18, 2008. Last Updated on February 11, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Community-Acquired Pneumonia (CAP)
Additional conditions recognized in this trial
More general conditions related to this trial
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Sponsors listed in this trial
Rib-X Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers